These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2614206)

  • 21. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
    Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of a thyrotropin-secreting pituitary adenoma (TSH-oma) with pasireotide LAR.
    van Eersel MEA; Meeuwisse-Pasterkamp SH; Muller Kobold AC; Meiners LC; den Dunnen WF; Hofland LJ; van den Berg G
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):877-879. PubMed ID: 28741655
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy.
    Blackhurst G; Strachan MW; Collie D; Gregor A; Statham PF; Seckl JE
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected clinical course during treatment of a TSH-secreting pituitary adenoma.
    Glynn N; Agha A
    Endocr Pract; 2013; 19(4):e88-91. PubMed ID: 23512395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenomas associated with hyperprolactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidally.
    Randall RV; Scheithauer BW; Laws ER; Abbound CF; Ebersold MJ; Kao PC
    Mayo Clin Proc; 1985 Nov; 60(11):753-62. PubMed ID: 3932786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary treatment of a combined somatotropin- and thyrotropin-secreting pituitary tumour with octreotide.
    Walsh JP; Glatthaar C; Pullan PT
    Aust N Z J Med; 1996 Feb; 26(1):124-5. PubMed ID: 8775546
    [No Abstract]   [Full Text] [Related]  

  • 28. Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review.
    Kurahashi K; Endo I; Kondo T; Morimoto K; Yoshida S; Kuroda A; Aihara KI; Matsuhisa M; Nakajima K; Mizobuchi Y; Nagahiro S; Abe M; Fukumoto S
    Intern Med; 2017 Sep; 56(18):2455-2461. PubMed ID: 28824054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone-, alpha-subunit and thyrotrophin-cosecreting pituitary adenoma in familial setting of pituitary tumour.
    Links TP; Monkelbaan JF; Dullaart RP; van Haeften TW
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):516-8. PubMed ID: 8109184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptors in the normal and abnormal anterior pituitary gland.
    Cronin MJ; Evans WS
    Clin Endocrinol Metab; 1983 Mar; 12(1):15-30. PubMed ID: 6303644
    [No Abstract]   [Full Text] [Related]  

  • 31. [TSH-secreting pituitary adenomas].
    Beckers A; Hennen G; Reznik M; Thibaut A; Stevenaert A
    Rev Med Liege; 1988 May; 43(10):396-402. PubMed ID: 2899901
    [No Abstract]   [Full Text] [Related]  

  • 32. Neoplasms of the anterior pituitary.
    McCarty KS; Bredesen DE; Vogel FS
    Neurosurgery; 1978; 3(1):96-104. PubMed ID: 210418
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSH.
    Colao A
    Nat Rev Endocrinol; 2015 Feb; 11(2):73-4. PubMed ID: 25534198
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of long-acting octreotide in suppressing hormonogenesis and tumor growth in thyrotropin-secreting pituitary adenomas: report of two cases.
    Gourgiotis L; Skarulis MC; Brucker-Davis F; Oldfield EH; Sarlis NJ
    Pituitary; 2001 Aug; 4(3):135-43. PubMed ID: 12138986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
    Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
    [No Abstract]   [Full Text] [Related]  

  • 36. Human pituitary adenomas. Recent advances in morphological studies.
    Giannattasio G; Bassetti M
    J Endocrinol Invest; 1990 May; 13(5):435-54. PubMed ID: 2166105
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor. Lack of hormonal response to bromocriptine.
    Carlson HE; Linfoot JA; Braunstein GD; Kovacs K; Young RT
    Am J Med; 1983 May; 74(5):915-23. PubMed ID: 6340497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Light and electron microscopic observation of the same mammosomatotroph cell in a mixed growth hormone- and prolactin-secreting pituitary adenoma--case report.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T
    Neurol Med Chir (Tokyo); 1993 Apr; 33(4):238-41. PubMed ID: 7685856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The medical treatment of prolactin and growth hormone-secreting pituitary tumours.
    Lancranjan I
    Acta Neurochir Suppl (Wien); 1990; 47():71-85. PubMed ID: 1968311
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro.
    de Bruin TW; Kwekkeboom DJ; Van't Verlaat JW; Reubi JC; Krenning EP; Lamberts SW; Croughs RJ
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1310-7. PubMed ID: 1430093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.